Small Molecule CDMO
Total Trials
1
As Lead Sponsor
As Collaborator
0
NCT04081597
A Study of Single Ascending Doses of STAR-101 in Healthy Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 29, 2020
Completion: Mar 31, 2020
Loading map...